Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03212066 · ClinicalTrials.gov registry record · NA

Master Mind Program Evaluation Study

A NA study of Substance Abuse and Mindfulness, sponsored by Innovation Research & Training.

Completed
Registry status
NA
Development phase
518
Enrollment target
1
Study location

NCT03212066 is a NA study of Substance Abuse and Mindfulness that has completed, run by Innovation Research & Training. The registered enrollment target is 518 participants, below the 5,251-participant average among 58 other Substance Abuse trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03212066, a NA study of Substance Abuse and Mindfulness, has completed, sponsored by Innovation Research & Training.

COMPLETED
Registry status
NA
Development phase
518 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to conduct a randomized controlled trial to evaluate the efficacy of the Master Mind program, a mindfulness education substance abuse prevention program. The program has the goal of enhancing coping strategies and decision-making skills and preventing substance abuse in late elementary school students.

Interventions

  • BEHAVIORAL Master Mind

Study Locations (1)

North Carolina

  • innovation Research & Training - Durham

Trial Details

FieldValue
Enrollment Target 518 participants
Start Date 2017-08-23
Est. Completion 2019-08-30
Phase NA

Sponsor

Innovation Research & Training

14 total trials

What the Registry Record Tells You About NCT03212066

The ClinicalTrials.gov registry entry for NCT03212066 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 518 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,251-participant average among 58 other Substance Abuse trials with a reported enrollment target (90% lower). The listed sponsor is Innovation Research & Training, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which Master Mind is the first listed.

NCT03212066 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03212066 about?

NCT03212066 is a clinical study titled "Master Mind Program Evaluation Study". The purpose of this study is to conduct a randomized controlled trial to evaluate the efficacy of the Master Mind program, a mindfulness education substance abuse prevention program. The program has the goal of enhancing coping strategies and decision-making skills and preventing substance abuse in ...

What is the current status of trial NCT03212066?

This trial is currently completed. It is a NA study. The enrollment target is 518 participants. The study started on 2017-08-23. Estimated completion is 2019-08-30.

What conditions does trial NCT03212066 study?

This clinical trial studies the following conditions: Substance Abuse, Mindfulness.

What interventions are being tested in trial NCT03212066?

The interventions under investigation include: Master Mind (BEHAVIORAL).

Who is sponsoring clinical trial NCT03212066?

This trial is sponsored by Innovation Research & Training, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03212066 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.